Antioxidant ACE inhibitors – Cover Issue 5

Trying to treat interdependent  diseases can be tricky, but not when one drug is capable of dealing with both.

Overproduction of angiotensin II by the angiotensin converting enzyme (ACE) leads to hypertension, which is associated with cardiovascular diseases such as high blood pressure, heart failure, coronary artery disease and kidney failure.  Hypertension has also been shown to play a role in oxidative stress, the imbalance of oxidants and antioxidants.  A drug that could treat both conditions would be of serious value to the medical community, and now researchers from the Indian Institute of Sciences have just synthesised a compound that shows the potential for doing just that.

Bhaskar Bhuyan and Govindasamy Mugesh synthesised several selenium analogues of the common ACE inhibitor, Captopril and demonstrated that not only were they capable of enzyme inhibition but also acted as antioxidants, scavenging peroxynitrite – the highly reactive intermediate known to cause cellular damage.

Read the full article online here – it’s free to access for 6 weeks!

Synthesis, characterization and antioxidant activity of angiotensin converting enzyme inhibitors
Bhaskar J. Bhuyan and Govindasamy Mugesh
Org. Biomol. Chem., 2011, 9, 1356-1365
DOI: 10.1039/C0OB00823k

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Multicomponent reactions and multi-catalytic cascade processes

This highly topical emerging area is the inside cover of OBC Issue 5.

Dhevalapally B. Ramachary and Sangeeta Jain at University of Hyderabad, India, believe in the development of different ways of producing chemical products that have an influence in our every day life in a more sustainable way, producing less waste and involving less money.

They believe that organic synthesis can be made much more efficient by designing processes in which multiple catalysts operate sequentially in “one-pot” with multiple components.

In this review, Ramachary and Jain describe the first systematic efforts toward the development of sequential one-pot combinations of multi-component reactions (MCRs) and multi-catalysis cascade (MCC) reactions.

If you want to read about this emerging area, ‘click’ here to read all of this in one pot!

Free to access for 6 weeks!

Sequential one-pot combination of multi-component and multi-catalysis cascade reactions: an emerging technology in organic synthesis
Dhevalapally B. Ramachary and Sangeeta Jain
Org. Biomol. Chem., 2011, 9, 1277-1300
DOI: 10.1039/C0OB00611D

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

HOT: Biosynthetic pathway for 7-deazapurines

Deazapurines are bicyclic heterocycles derived from purine where one nitrogen atom is replaced by a carbon. Although they have been widely studied in recent years, the mechanistic understanding of the biosynthesis of 7-deazapurines has always been intriguing.

There is a question that inevitably arise when looking at the biosynthetic pathway of deazapurines: Where does N-7 go? 

Now, Professor Moody and his group at University of Nottingham have solved this mystery by using a doubly labelled purine-adenine and following it up by NMR spectroscopy and mass spectrometry.
Their conclusions are supported and support a recent study published in Biochemistry.

If you want to find out more about the fate of this nitrogen and the mechanistic understanding of the biosynthesis of deazapurines, read this HOT paper which is free to access until 16th March.

7-Deazapurine biosynthesis: NMR study of toyocamycin biosynthesis in Streptomyces rimosus using 2-13C-7-15N-adenine
Ugo Battaglia, Jed E. Long, Mark S. Searle and Christopher J. Moody
Org. Biomol. Chem., 2011
DOI: 10.1039/C0OB01054E

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

HOT: Highly selective formation of lantibiotic conjugates

Lantibiotics (and there is no spelling mistake) are a potential new class of antibiotics for clinical applications and food preservation. Their drawback is however their inability to penetrate the outer membranes of Gram-negative bacteria.

John Vederas and colleagues, at University of Alberta in Canada, try to overcome this problem by developing new ‘siderophores – transporters’ able to deliver lantibiotics to the targeted bacteria.

If you want to find out more about what happened next and the scope and limitation of siderophore-mediated drug transport for the development of new antibiotics download this HOT article which is free to access until 8th March.

Chemical synthesis and biological evaluation of gallidermin-siderophore conjugates
Sabesan Yoganathan, Clarissa S. Sit and John C. Vederas
Org. Biomol. Chem., 2011
DOI: 10.1039/C0OB00846J

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

HOT: One step closer to the synthesis of an unstable antibiotic

Nature has been giving organic chemists inferiority complexes for many, many years, so it is always good to see a neat piece of synthesis for a tricky natural product.

The structure of viridenomycin – an antibiotic with anti-tumor activity – has been known for 20 years, but attempts to synthesise it thus far have failed due to its complex structure and inherent instability. Now, Andy Whiting and colleagues from Durham University have synthesised fragments suitable for constructing a particularly unstable part of viridenomycin via a series of cross-coupling reactions.

They focused on the northern polyene fragment, synthesising several analogues with better isometric ratios and increased stability towards photoisomerisation than the original tetraene fragment.  The authors hope that their method may help to achieve the total synthesis of this valuable complex molecule.

Read how they did it online – the article is free to access for 4 weeks!

Studies towards the synthesis of the northern polyene of viridenomycin and synthesis of Z-double bond analogues
Jonathan P. Knowles, Victoria E. O′Connor and Andrew Whiting
Org. Biomol. Chem., 2011, Advance Article
DOI: 10.1039/C0OB00977F

 

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

HOT: Aryl azides go with the flow

Organic azides are considered to be amongst the most hazardous chemicals and therefore not amongst the most popular within  synthetic chemistry communities. In organic chemistry they are commonly used as a way to introduce an amine group, which makes them key compounds for synthetic chemists.

Steven Ley, Ian Baxendale and their group at University of Cambridge, describe in these back to back papers the development of a flow process for the synthesis of alkyl and aryl azides in high conversions. One of the key features of this flow procedure is the introduction of a new monolithic triphenylphosphine reagent that allows the use of triphenylphosphine in flow to provide high purity products without the need of further purification steps.

They also describe a general protocol for the in-line purification of the intermediates. They incorporate the azide synthesis and purification process into a multistep flow sequence to generate a collection of aminocyanotriazoles in a fully automated fashion.

Now you can read these very interesting and HOT papers which are free to access until the 8th March.

Download both papers here.

Flow synthesis of organic azides and the multistep synthesis of imines and amines using a new monolithic triphenylphosphine reagent
Catherine J. Smith, Christopher D. Smith, Nikzad Nikbin, Steven V. Ley and Ian R. Baxendale
Org. Biomol. Chem., 2011
DOI: 10.1039/C0OB00813C

A fully automated, multistep flow synthesis of 5-amino-4-cyano-1,2,3-triazoles
Catherine J. Smith, Nikzad Nikbin, Steven V. Ley, Heiko Lange and Ian R. Baxendale
Org. Biomol. Chem., 2011
DOI: 10.1039/C0OB00815J

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Perspective: Multivalent inhibitors of lectins

Sebastien G. Gouin and his team at University of Nantes, France, review some of the important structural features in the synthesis of multivalent glycoconjugates for a tight binding with specific lectins.

Read this review on multivalent inhibitors of lectins from a different and very interesting point of view: how the scaffold influences potency.

Insights in the rational design of synthetic multivalent glycoconjugates as lectin ligands
David Deniaud, Karine Julienne and Sébastien G. Gouin
Org. Biomol. Chem., 2011, 9, 966-979
DOI: 10.1039/C0OB00389A, Perspective

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Size is important – OBC Cover Issue 4

Cyclophanes have been used as molecular systems in host-guest complexations due to their ability to encapsulate other molecules through various non-covalent interactions.
Cyclophanes  can be rationally designed by choosing the right components, similar to  Lego® bricks. However, the features of these ‘lego bricks’ required to build the desired cyclophanes with the requisite biomolecular recognition properties have not been widely explored.

Now, Danaboyina Ramaiah and colleagues at NIIST in India have revealed some of the features to bear in mind when designing cyclophanes. They concluded by saying that  that the cavity size and its rigidity, the aromatic surface and nature of bridging units dictate the stability of the supramolecular complex and thereby govern the biomolecular recognition properties of cyclophanes.

You can now download this article, which is free to access until mid-March.

Study of cavity size and nature of bridging units on recognition of nucleotides by cyclophanes
Prakash P. Neelakandan, Paramjyothi C. Nandajan, Baby Subymol and Danaboyina Ramaiah
Org. Biomol. Chem., 2011, 9, 1021-1029
DOI: 10.1039/C0OB00673D, Paper

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

HOT: The workings of T. cruzi trans-sialidase

T. cruzi, the causative agent of Chagas disease, relies on its enzyme trans-sialidase for part of its infectivity. Robert Field et al., from several collaborating institutions worldwide, have studied this enzyme, highlighting the wide range of structures and functionalities that it can accommodate. This study has demonstrated important features for potential inhibitor design (a therapeutic target for Chagas’ disease) and also opens up possibilities for using the versatility of this enzyme more generally as a catalyst for α-(2→3)-sialylglycoconjugate synthesis.

This HOT article is now free to access until 22nd February.

Probing the acceptor substrate binding site of Trypanosoma cruzi trans-sialidase with systematically modified substrates and glycoside libraries
Jennifer A. Harrison, K. P. Ravindranathan Kartha, Eric J. L. Fournier, Todd L. Lowary, Carles Malet, Ulf J. Nilsson, Ole Hindsgaul, Sergio Schenkman, James H. Naismith and Robert A. Field
Org. Biomol. Chem., 2011, Advance Article
DOI: 10.1039/C0OB00826E, Paper

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

HOT: PBD-DNA adduct formation is reversible. Evidence by Thurston

PBDs (pyrrolo[2,1-c][1,4]benzodiazepines) and their interaction with DNA is an area of active research.

PBDs belong to a family of biologically active an DNA-interactive antibiotics having unique mechanism of action compared with other DNA-binding agents. Up until now, there have been several reports in literature suggesting that PBD-DNA adduct formation might be reversible; however, no evidence of this reversibility had been reported.

For the first time, in this paper, David Thurston and colleagues at the School of Pharmacy at University of London, investigate the adduct formation of PBDs with DNA and its reversibility using HPLC/MS methodology and polarised light spectroscopy.

Read about some of their findings in this OBC HOT paper which is free to access until the 22nd February.

Observation of the reversibility of a covalent pyrrolobenzodiazepine (PBD) DNA adduct by HPLC/MS and CD spectroscopy
Khondaker M. Rahman, Colin H. James and David E. Thurston
Org. Biomol. Chem., 2011, Advance Article
DOI: 10.1039/C0OB00762E, Paper

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)